Regresar

Foto de Maggioni A.P.

Maggioni A.P.

1148

Coauthors

17

Documentos

Volumen de publicaciones por año

Cargando gráfico

Año de publicación	Num. Publicaciones
2008	1
2012	1
2015	1
2016	1
2017	3
2018	2
2019	4
2020	1
2021	2
2022	1

Publicaciones por áreas de conocimiento

Cargando gráfico

Área de conocimiento	Num. Publicaciones
Enfermedad cardiovascular	11
Medicina interna	10
Diabetes	2
Medicamento	2
Cáncer	1
Neurología	1
Farmacología	1

Publicaciones por áreas temáticas

Cargando gráfico

Área temática	Num. Publicaciones
Enfermedades	17
Farmacología y terapéutica	11
Medicina y salud	8
Fisiología humana	2
Problemas sociales y servicios a grupos	2
Cirugía y especialidades médicas afines	2
Salud y seguridad personal	1
Ginecología, obstetricia, pediatría, geriatría	1

Principales fuentes de datos

Origen	Num. Publicaciones
Scopus	17
Google Scholar	10
RRAAE	0

Cargando gráfico

Coautores destacados por número de publicaciones

Coautor	Num. Publicaciones
Yusuf S.	15
Bosch J.J.	14
Avezum A.J.	13
Dagenais G.R.	12
Probstfield J.L.	12
Rydén L.E.	12
Fox K.A.A.	12
PATRICIO LOPEZ -JARAMILLO	11
Lonn E.M.	11
DIaz R.	11

Cargando gráfico

Top Keywords

Cargando gráfico

Publicaciones del autor

Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease

Abstract: Background: The combination of 2.5 mg rivaroxaban twice daily and 100 mg aspirin once daily compared

Palabras claves:

aspirin, Coronary artery disease, Mortality , Peripheral artery disease, rivaroxaban

Anand S.S., Avezum A.J., Berkowitz S.D., Bhatt D.L., Bosch J.J., Branch K.R.H., Connolly S.J., Dagenais G.R., Eikelboom J.W., Felix Camilo, Fox K.A.A., Guzik T.J., Hart R.G., Maggioni A.P., Muehlhofer E., Sharma M., Shestakovska O., Yusuf S.

Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis

Abstract: BACKGROUND: Patients treated with antithrombotic drugs are at risk of bleeding. Bleeding may be the

Palabras claves:

aspirin, hemorrhage, neoplasms, rivaroxaban

Aboyans V., Alings M., Anand S.S., Avezum A.J., Berkowitz S.D., Bhatt D.L., Bosch J.J., Connolly S.J., Cook-Bruns N., Eikelboom J.W., Felix Camilo, Fox K.A.A., Hart R.G., Maggioni A.P., Moayyedi P., O’Donnell M., Rydén L.E., Shestakovska O., Verhamme P.B., Widimsky P., Yusuf S., Zhu J.

Health-Related Quality of Life and Mortality in Heart Failure The Global Congestive Heart Failure Study of 23000 Patients From 40 Countries

Abstract: BACKGROUND: Poor health-related quality of life (HRQL) is common in heart failure (HF), but there ar

Palabras claves:

health status, Heart Failure, Left, prognosis, quality of life, Ventricular function

Alhabib K.F., Balasubramanian K., Bayes-Genis A., Budaj A.J., Dans A.M., Dokainish H., Dzudie A., Ezekowitz J.A., Fox K.A.A., Fukakusa B., Grinvalds A., Johansson I., Joseph P.G., Kamath D., Karaye K.M., Lanas F.T., Lund L.H., Maggioni A.P., Makubi A., McCready T., McMurray J.J.V., PATRICIO LOPEZ -JARAMILLO, Probstfield J.L., Silva-Cardoso J., Sliwa K., Temizhan A., Teo K.K., Wittlinger T., Yusuf S.

Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy

Abstract: Background and Purpose: Covert brain infarcts are associated with cognitive decline. It is not known

Palabras claves:

aspirin, COGNITION, infarction, rivaroxaban, white matter

Avezum A.J., Berkowitz S.D., Bhatt D.L., Bosch J.J., Branch K.R.H., Casanova A., Connolly S.J., Dagenais G.R., DIaz R., Dyal L., Eikelboom J.W., Ertl G., Fox K.A.A., Hart R.G., Keltai K., Keltai M., Kim J.H., Liang Y., Liu L., Lonn E.M., Maggioni A.P., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Reeh K.W., Rydén L.E., Sharma M., Smith E.E., Störk S., Tonkin A.M., Varigos J.D., Vinereanu D., Yusuf S., Zhu J.

Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial

Abstract: Background: Covert vascular disease of the brain manifests as infarcts, white matter hyperintensitie

Palabras claves:

Anticoagulant, Clinical trial, COGNITION, magnetic resonance imaging, prevention, silent infarct

Avezum A.J., Berkowitz S.D., Bhatt D.L., Bosch J.J., Branch K.R.H., Casanova A., Connolly S.J., Cook-Bruns N., Dagenais G.R., DIaz R., Eikelboom J.W., Ertl G., Fox K.A.A., Ha J.W., Hart R.G., Keltai K., Keltai M., Kim J.H., Liang Y., Liu L., Lonn E.M., Maggioni A.P., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Sharma M., Smith E.E., Störk S., Tonkin A.M., Varigos J.D., Vinereanu D., Wong G., Yuan F., Yusuf S., Zhu J.